OBN Awards 2021 – Finalists Announced |
|
Hello
We are pleased to announce details of the companies that have been shortlisted to the final round of the 13th Annual OBN Awards, the most coveted awards event in UK life sciences.
The number and quality of entries was incredibly strong again this year, and the first-round judges were impressed by the quality and innovation presented.
The final judging process will now commence, with the winners announced live and in-person at the OBN Awards on Thursday 25 November at The Ashmolean Museum in Oxford.
If you would like to join us on the night to celebrate the finalists and winners, we have a limited number of tickets currently available – click below to book.
|
|
Congratulations to the OBN Awards 2021 Finalists:
|
|
-
SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics)
-
Novai is a British biotechnology start-up, commercialising DARC Technology, an exploratory retinal biomarker with AI
-
SwitchRx aims to provide healthcare professionals with the most current and useful information to guide their clinical practice when adjusting their patient's psychotropic treatment regimens
|
|
Best Emerging Biotech Company, Kindly sponsored by LifeSci
|
|
-
Quell Tx aims to bring transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs
-
Vaccitech develops immunotherapies and vaccines for the treatment and prevention of infectious diseases and cancer. Vaccitech is a spin-out company from the University of Oxford’s Jenner Institute, one of the most prestigious vaccine research centres in the world
-
Artios Pharma are developing breakthrough cancer treatments that target DNA Damage Response (DDR) pathways to specifically destroy certain devastating cancers that are difficult to treat
-
Arctoris offers a fully automated research lab based in Oxford, accessible online 24/7. Your expert resource for drug discovery in cell & molecular biology and biochemistry
|
|
-
Crescendo Biologics is focused on novel T cell enhancing therapeutics in immuno-oncology
-
Healx have created the world’s most efficient AI platform for rare diseases. It makes drug discovery faster, smarter and safer, and supports discovery and translation of new treatments towards the clinic
-
C4X Discovery exploits cutting edge technologies to design and create small-molecule candidates in a range of therapeutic areas
|
|
-
Cerca Magnetics have developed and brought to market the world’s first commercial, fully integrated brain imaging device based on optically-pumped magnetometers (OPMs)
-
Koalaa offer comfortable, easy-to-fit, affordable prosthetic arms for kids and adults - a below elbow soft-prosthetic (The ALX) and a soft-prosthetic for partial hands and fingers (The Paww)
-
Charco is a medtech start-up working on a system for people with Parkinson's to improve their quality of life
|
|
Best Emerging Medtech Company
|
|
-
Ultromics is a global health technology firm which provides autonomous echocardiography analysis through innovative AI solutions
-
PredictImmune is a global biotechnology company which guides personalised treatment of patients with immune-mediated diseases
-
Kinomica is a pioneering precision medicine research and diagnostics company specialising in cell signalling
|
|
Best Established Medtech Company Kindly sponsored by Milton Park
|
|
-
Inivata is a leader in liquid biopsy. Its InVision® platform unlocks key genomic information from a simple blood test to transform patient cancer care
-
Lightpoint develops and markets innovative technologies for intra-operative cancer detection to improve the lives of people with cancer by transforming the efficacy of cancer surgery
-
Isansys is a world leading digital healthcare company which has developed the most complete, scalable and simple-to-use advanced patient monitoring platform - the Patient Status Engine
-
Yaqrit is a clinical stage life sciences company developing end-to-end solutions for patients with advanced liver disease
|
|
Most Transformative Digital Healthcare Company Kindly sponsored by Ipsen
|
|
-
GENinCode products combine genetic and clinical data to risk assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease.
-
Sensyne Health connect patients, clinicians and researchers, which collectively help healthcare professionals deliver better patient care while curating vital data to support the next generation of medical research
-
Hertility Health are the only company in the world that offers tailored and comprehensive hormone testing, whilst also providing in-house experts in reproductive medicine, fertility, PCOS, endometriosis and gynaecology
|
|
-
Precision for Medicine is an oncology specialty CRO that provides clinical research services and application of metrics-driven project management to optimise oncology drug development
-
High Force Research is a chemical research and development company which collaborates with industry, discovery groups, start-up and academic spin-off companies in synthesising and analysing new materials for proof-of-concept, route evaluation and process development/scale-up, stability trials and toxicological studies
-
Seda Pharmaceutical Development Services provide Pharmaceutical Development and Clinical Pharmacology services and consultancy to the Pharma and Biotechnology Industry enabling the rapid and efficient development of optimal medicinal products by providing coherent and synergistic support
-
Cellomatics Biosciences is a laboratory-based CRO which specialises in oncology, immuno-oncology, immunology, inflammation and respiratory therapeutic areas offering bespoke and innovative preclinical in vitro assay services to biotechs, pharma companies and academic groups
|
|
Most Impactful Business Support Organisation |
|
-
The Milner Therapeutics Institute encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies.
-
First Create The Media Is a communications consultancy for people that work in science. The company provides consultancy, copywriting, podcast and video production, science communication training and one-to-one coaching
-
FOCUS provide bespoke insurance solutions for commercial, business and private clients
|
|
-
Presymptom Health is a pioneering medtech company that creates diagnostic tests to detect illnesses earlier to help save lives.
-
Sonrai Analytics automate laborious data processes, harness Artificial Intelligence, and speed up new drug & healthcare developments
-
Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one
|
|
The Most Impactful UK Deal |
|
-
Oxford Biomedica’s key role in the manufacturing of the COVID-19 vaccine saw the production of the vaccine achieved at unprecedented scale and pace, creating a manufacturing capacity in a matter of less than three months when this would normally take years
-
Horizon Discovery, a cell engineering company focused on using gene editing and gene modulating tools to accelerate drug development and scientific innovation was acquired by scientific technology innovator and leader PerkinElmer Inc, in December 2020 for approximately £296m ($383m)
-
Charnwood Molecular acquired Aurelia Bioscience, a pre-clinical biology CRO in June 2021 which has allowed Charnwood Molecular to offer integrated drug discovery services to pharmaceutical, biotech and chemistry clients
Please note: The winner of the ‘Special Recognition Award’, Sponsored by OBN, will be announced on the night of the OBN Awards on 25 November.
|
|
Congratulations to all our finalists - we look forward to celebrating with you.
Best wishes
The OBN team
|
|
|
|
|
|
|
